Remdesivir yana taimakawa magance COVID-19. Ashe mun kare ne?
Coronavirus Abin da kuke buƙatar sani Coronavirus a Poland Coronavirus a Turai Coronavirus a cikin duniya Taswirar Jagorar Tambayoyi akai-akai #Bari muyi magana akai

Remdesivir magani ne na rigakafi da aka ba marasa lafiya da ke da cututtukan SARS-CoV-2. Ya zuwa yanzu, ita ce kawai wakili da aka yi amfani da shi don kula da COVID-19, wanda hukumomin Amurka da na Turai suka amince da su a hukumance. A cewar bayanai daga Ma'aikatar Lafiya, an ba da umarnin sama da 100 a cikin Afrilu. guda remdesivir, sau da yawa fiye da na watannin baya. Duk da haka, a cewar likita Bartosz Fiałek, yana da wuya a ƙididdige yawan adadin kuɗi.

  1. Remdesivir magani ne na rigakafi da aka samar da asali don yaƙar cutar Ebola
  2. A halin yanzu, ana ba da shi a asibitoci ga marasa lafiya da suka kamu da cutar ta coronavirus, waɗanda matakan saturation suna faɗuwa
  3. Bukatun remdesivir na karuwa akai-akai, wanda shine dalilin da ya sa ma'aikatar lafiya kwanan nan ta kara yawan odar
  4. Ba a amfani da miyagun ƙwayoyi a kowane asibiti, haka ma - ba mu san adadin mutanen da ke buƙatar maganin remdesevir ba - ya jaddada likita Bartosz Fiałek.
  5. Don ƙarin labaran coronavirus, duba shafin gida na TvoiLokony

Remdesivir yana ba da damar rage lokacin asibiti na marasa lafiya na COVID-19

Remdesivir har yanzu shine kawai maganin da ake amfani dashi a halin yanzu don kula da marasa lafiya na COVID-19. Duk da cewa daga lokaci zuwa lokaci bayanai game da tasiri far tare da sauran jamiái zo a, har yanzu ba su samu koren haske a lõkacin da ta je taro da hukuma magani.

Remdesivir shine kawai magani da Hukumar Abinci da Magunguna ta Amurka (Hukumar Abinci da Magunguna ta Amurka) ta amince da ita sannan kuma EMA (Hukumar Kula da Magunguna ta Turai) don amfani da mutane daga shekaru 12 a cikin marasa lafiya da ke fama da cutar huhu na COVID-19 waɗanda ke buƙatar iskar oxygen, in ji Bartosz Fiałek, likita.

Ana gudanar da bincike kan wasu magunguna da yawa, kamar su monoclonal antibodies, cocktails da aka yi da waɗannan ƙwayoyin cuta, irin su REGN-COV2, wanda aka bai wa tsohon shugaban Amurka Donald Trump.. Akwai glucocorticosteroids, irin su dexamethasone, wanda kuma yana da tasiri mai kyau akan yanayin COVID-19, watau rage haɗarin mutuwa saboda mummunan yanayin cutar. Akwai kuma magungunan da ke yin maganin daskarewar jini, irin su heparins marasa nauyi, ko magungunan kashe jini. Baya ga remdesivir, wanda aka amince don amfani da shi wajen jiyya na COVID-19, sauran magungunan da aka ambata an yarda dasu ta hanyar sharadi, watau don amfanin gaggawa (EUA), in ji Fiałek.

  1. Magani don COVID-19 wanda likitoci ke da babban bege akai. Wani sakamako mai ban sha'awa na bincike

– An samar da Remdesivir don yaki da cutar Ebola kuma an nuna shi ya zama ingantaccen maganin rigakafi don rage haɗarin mutuwa daga COVID-19 da rage lokacin asibiti daga matsakaicin 15 zuwa matsakaicin kwanaki 11.i. Don haka za ku ga cewa miyagun ƙwayoyi yana shafar yanayin cutar. Remdesivir tare da glucocorticosteroids ko monoclonal antibodies na iya ba da izini don haɓaka samfurin warkewa mai yiwuwa wanda zai taimaka wa marasa lafiya da yawa. A halin yanzu, duk da haka, ba mu da maganin da zai iya haifar da cutar COVID-19, kamar yadda, alal misali, a cikin yanayin streptococcal angina, maganin rigakafi ne na rukunin penicillin. Don haka, adadi mai yawa na mace-mace - amma ƙasa da placebo - a cikin mutanen da suka karɓi remdesivir, ya bayyana ƙwararrun a cikin ilimin rheumatology.

Remdesivir don Coronavirus. Ashe mun kare ne?

Mun tambayi ma’aikatar lafiya ko yaya hannayen maganin remdesivir suke a halin yanzu.

"A cikin watanni 4 da suka gabata, an ba da ayyuka 148 zuwa Poland. na miyagun ƙwayoyi, ciki har da 52 dubu a cikin Maris kadai. A watan Afrilu, za mu karɓi 102 dubu. Tabbas mun ƙara umarni, amma abin takaici Gileyad ba zai iya ƙara ƙarfin samarwa don biyan bukatun duk masu zuwa ba, kuma wannan shine kawai masana'antar miyagun ƙwayoyi "- mun karanta a cikin bayanin da Ma'aikatar Sadarwar Lafiya ta aika.

  1. "A cikin kwanaki 10 za mu iya samun mutuwar mutane dubu daga COVID-19"

Kamar yadda kuke gani, odar na wata mai zuwa ya fi girma fiye da na baya, amma wannan ya isa wannan magani? – Da wuya a ce. Abubuwan da MZ ke magana game da su ba su yiwuwa a yi tsokaci akai, saboda dole ne in san kididdigar bukatun asibiti. Ba a amfani da maganin a kowane asibiti, haka ma - ba mu san adadin mutane nawa ke buƙatar magani tare da remdesevir ba. Yana da kyau karanta ganyen shayi.. Halin yana da ƙarfi. dubu 100. oda guda don 5 dubu. cututtuka, kuma daban-daban tare da 35 dubu. Ba shi yiwuwa a tantance adadin mutane nawa suka ƙare a asibitocin da ke ɗauke da remdesivir a cikin albarkatun magani. Wataƙila asibitocin Covid suna yi, amma kuma akwai sassan a asibitocin poviat waɗanda ke karɓar mutanen da suka kamu da cutar ta SARS-CoV-2, inda ba za a iya samun maganin ba, in ji likita Bartosz Fiałek.

Ma'aikatar lafiya kuma ba ta da kididdiga. Babu takamaiman ƙayyadaddun ƙa'idodi don amfani, mun koya kawai cewa "likitan da ke kula da marasa lafiya a asibiti ya yanke shawarar".

  1. Coronavirus a Poland - ƙididdigewa don ɓarnawar ɓoyayyiya [YANZU DATA]

- Wadannan dubu 100 ba zai wadatar ba idan za a gudanar da su a duk inda ake jinyar masu cutar COVID-19. Da farko, duba nau'in sashi na miyagun ƙwayoyi - 1 vial ya ƙunshi 100 MG na miyagun ƙwayoyi, kuma an ba mai haƙuri 200 MG a rana ta farko sannan kuma 100 MG har zuwa kwanaki 10 (watakila ya fi guntu, duk ya dogara da shi. yanayin asibiti na majiyyaci) - ci gaba Fiałek.

- Duk da haka, karuwar girman siyan remdesevir na iya nuna cewa Ma'aikatar Lafiya ta san girman bala'in annoba - in ji likita.

Har ila yau karanta:

  1. Mutane nawa ne a Poland suka mutu bayan rigakafin COVID-19? Bayanan gwamnati
  2. Ana samun ƙarin matasa marasa lafiya a asibitoci saboda COVID-19
  3. Likitoci suna gaya muku yadda ake sanin ko COVID-19 ya bar burbushi a jikin ku
  4. Nau'in rigakafin COVID-19. Ta yaya vector ya bambanta da rigakafin mRNA? [MUN BAYYANA]

Abubuwan da ke cikin gidan yanar gizon medTvoiLokony an yi niyya don haɓakawa, ba maye gurbin, tuntuɓar mai amfani da gidan yanar gizon da likitansu ba. An yi nufin gidan yanar gizon don dalilai na bayanai da ilimi kawai. Kafin bin ilimin ƙwararrun ƙwararrun, musamman shawarwarin likita, wanda ke ƙunshe a kan Yanar Gizonmu, dole ne ku nemi likita. Mai Gudanarwa ba ya ɗaukar kowane sakamako sakamakon amfani da bayanan da ke cikin gidan yanar gizon. Kuna buƙatar shawarwarin likita ko takardar sayan magani ta e-sikelin? Je zuwa halodoctor.pl, inda za ku sami taimakon kan layi - da sauri, cikin aminci kuma ba tare da barin gidanku ba.Yanzu zaku iya amfani da e-consultation kuma kyauta a ƙarƙashin Asusun Kiwon Lafiya na Ƙasa.

Leave a Reply